Transcatheter aortic valve implantation (TAVI) has been touted for “revolutionizing the field of cardiology,” as the preferred treatment for most patients over age 70 years with severe aortic stenosis ...
Valve-in-valve (ViV) transcatheter procedures for a failed aortic bioprosthesis are associated with a lower risk of in-hospital mortality compared with a repeat surgical aortic valve replacement, but ...
New data showing five-year outcomes at a single center with the very earliest transcatheter aortic valve implant (TAVI) devices indicate that they are durable and "may last as long as many surgical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback